Participant flow18

How many started, completed or left each group, period by period.

1 to 18 of 18

Period	Milestone	Group	Participants
Overall Study	STARTED	Kras Mutant Patients	28
Overall Study	STARTED	EGFR Mutant Patients	35
Overall Study	STARTED	EGFR and Kras Wild Type Patients	34
Overall Study	STARTED	Patients With EML4-ALK Translocation	22
Overall Study	STARTED	Modified EGFR Mutant Patients	31
Overall Study	STARTED		3
Overall Study	COMPLETED	Kras Mutant Patients	0
Overall Study	COMPLETED	EGFR Mutant Patients	0
Overall Study	COMPLETED	EGFR and Kras Wild Type Patients	0
Overall Study	COMPLETED	Patients With EML4-ALK Translocation	1
Overall Study	COMPLETED	Modified EGFR Mutant Patients	1
Overall Study	COMPLETED		0
Overall Study	NOT COMPLETED	Kras Mutant Patients	28
Overall Study	NOT COMPLETED	EGFR Mutant Patients	35
Overall Study	NOT COMPLETED	EGFR and Kras Wild Type Patients	34
Overall Study	NOT COMPLETED	Patients With EML4-ALK Translocation	21
Overall Study	NOT COMPLETED	Modified EGFR Mutant Patients	30
Overall Study	NOT COMPLETED		3

Source ClinicalTrials.govtrials-2026-11-12-0.4.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01124864/flow